Didymin: an orally active citrus flavonoid for targeting neuroblastoma

Neuroblastoma, a rapidly growing yet treatment responsive cancer, is the third most common cancer of children and the most common solid tumor in infants. Unfortunately, neuroblastoma that has lost p53 function often has a highly treatment-resistant phenotype leading to tragic outcomes. In the contex...

Descripción completa

Detalles Bibliográficos
Autores principales: Singhal, Sharad S., Singhal, Sulabh, Singhal, Preeti, Singhal, Jyotsana, Horne, David, Awasthi, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438742/
https://www.ncbi.nlm.nih.gov/pubmed/28187004
http://dx.doi.org/10.18632/oncotarget.15204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438742/
https://www.ncbi.nlm.nih.gov/pubmed/28187004
http://dx.doi.org/10.18632/oncotarget.15204

Ejemplares similares